Edition:
United Kingdom

Syros Pharmaceuticals Inc (SYRS.OQ)

SYRS.OQ on NASDAQ Stock Exchange Global Select Market

10.52USD
16 Jan 2018
Change (% chg)

$0.01 (+0.10%)
Prev Close
$10.51
Open
$10.69
Day's High
$10.76
Day's Low
$10.36
Volume
60,988
Avg. Vol
92,669
52-wk High
$24.35
52-wk Low
$6.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.523
Mar '17 1.10 -0.492
FY 2016 Dec '16 0.32 -0.200
Sep '16 0.00 -0.649
Jun '16 0.00 -0.608
Mar '16 0.00 -0.542
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 0.00 0.00 0.00 --
Quarter Ending Jun-18 4 0.00 0.00 0.00 --
Year Ending Dec-18 6 0.00 0.00 0.00 19.91
Earnings (per share)
Quarter Ending Mar-18 4 -0.47 -0.16 -0.63 --
Quarter Ending Jun-18 4 -0.67 -0.62 -0.72 --
Year Ending Dec-18 6 -2.62 -2.00 -2.99 -4.31
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.81 36.90
P/E High - Last 5 Yrs. -- 40.83 45.68
P/E Low - Last 5 Yrs. -- 23.55 24.26
Beta -- 0.89 0.88
Price to Sales (TTM) 194.91 4.04 6.58
Price to Book (MRQ) 3.52 4.89 5.79
Price to Tangible Book (MRQ) 3.52 5.78 7.43
Price to Cash Flow (TTM) -- 23.51 25.31
% Owned Institutions 76.16 1.12 1.86

Dividends

  Company industry sector
Dividend Yield -- 1.53 1.46
Dividend Yield - 5 Year Avg -- 2.16 2.03
Dividend 5 Year Growth Rate -- 4.33 5.32
Payout Ratio(TTM) -- 47.39 45.96

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.35 6.77
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 6.98
Sales - 5 Yr. Growth Rate -- 10.01 10.31
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.90 7.07 7.71
EPS (TTM) vs TTM 1 Yr. Ago 25.05 -- --
EPS - 5 Yr. Growth Rate -- 10.04 11.11
Capital Spending - 5 Yr. Growth Rate -- 15.13 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.48 2.55
Current Ratio (MRQ) 9.00 3.49 3.56
LT Debt to Equity (MRQ) 0.01 11.43 13.94
Total Debt to Equity (MRQ) 0.12 17.67 20.02
Interest Coverage (TTM) -- 40.21 35.70

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.37 54.98
Gross Margin - 5 Yr. Avg. -- 52.53 52.60
EBITD Margin (TTM) -3,436.95 -- --
EBITD - 5 Yr. Avg -- 18.51 15.30
Operating Margin (TTM) -3,540.97 14.68 5.68
Operating Margin - 5 Yr. Avg. -- 14.28 10.55
Pre-Tax Margin (TTM) -3,503.03 15.12 6.55
Pre-Tax Margin - 5 Yr. Avg. -- 14.59 10.95
Net Profit Margin (TTM) -3,503.03 11.31 2.79
Net Profit Margin - 5 Yr. Avg. -- 10.93 7.23
Effective Tax Rate (TTM) -- 24.36 24.25
Effective Tax Rate - 5 Yr. Avg. -- 23.45 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 25,782 935,327,385 838,511,530
Net Income/Employee (TTM) -903,145 109,328,143 97,909,667
Receivable Turnover (TTM) -- 5.89 6.15
Inventory Turnover (TTM) -- 2.72 3.54
Asset Turnover (TTM) 0.01 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.54 11.78 11.22
Return on Assets - 5 Yr. Avg. -- 12.80 12.19
Return on Investment (TTM) -57.93 14.96 14.28
Return on Investment - 5 Yr. Avg. -- 16.75 15.96
Return on Equity (TTM) -58.66 16.51 15.94
Return on Equity - 5 Yr. Avg. -- 17.80 17.22
  1 Year 3 Year 5 Year
Sales % 0.00 -- --
EPS (TTM) % -165.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Syros Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 16.91 12.27 72 16
13 Week -37.63 -42.84 3 18
26 Week -38.47 -45.69 7 22
52 Week -10.09 -26.74 27 21
YTD 8.02 3.65 71 14
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.16%
# of Holders: 96
Total Shares Held: 20,027,400
3 Mo. Net Change: 17,351
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 1
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.